Wintergreen Acquisition Shares Stay Near Highs As KIKA Deal Looms

Wintergreen Acquisition Shares Stay Near Highs As KIKA Deal Looms

June 1, 2026

New York, May 31, 2026, 18:04 EDT

  • Wintergreen Acquisition Corp. was last seen at $10.35 on light volume. U.S. markets were closed Sunday.
  • The stock is trading on its planned deal with KIKA Technology, not on its operating results right now.
  • Investors are set to watch for proxy, vote and redemption updates tied to the SPAC deal next week.

Wintergreen Acquisition Corp. (Nasdaq) ended the holiday-shortened week flat, trading near $10.35. Latest volume came in at 5,319 shares. That leaves the blank-check firm with a market cap of around $75.6 million.

That’s important now since Wintergreen isn’t a usual operating company. Wintergreen is a SPAC, or special purpose acquisition company, a shell that raises money in an IPO before it looks to merge with a private firm. Nasdaq marks Memorial Day, May 25, as a market holiday in 2026, with the next full U.S. market holiday Juneteenth, June 19.

KIKA Technology Inc. is the proposed target. Wintergreen said in its quarterly filing it signed a merger agreement with KIKA on Nov. 17. KIKA is set to become a wholly owned unit of Wintergreen, which plans to take the name “KIKA Inc.”

Deal terms put the focus on what KIKA holders get. They’re in line to receive about 7.98 million Wintergreen shares. The target is valued at $80 million, with the per-share price set to match the SPAC redemption price—the same price public investors can choose if they cash out instead of holding shares after the merger.

Wintergreen’s filings help explain the way the stock has moved. By March 31, the company reported $57.9 million in marketable securities sitting in its trust account and $1.18 million in cash for operating needs. Net income came in at $371,705 for the first quarter, most of it coming from trust investment income rather than revenue from operations.

KIKA plans to shift the stock’s shape. According to its S-4, KIKA is a Cayman holding company. Its Hong Kong arm runs AdTech Dynamic Matching Technology services. The adtech market is crowded, the filing says, with agencies, old media, and other ad-matching firms all able to push prices down.

Adtech stocks traded in different directions ahead of the weekend. Shares of The Trade Desk climbed 2%. PubMatic picked up 2.2%. Magnite fell 0.8%. Wintergreen investors got a preview of what the public adtech market might look like for them if the buyout is completed.

SPAC deals are still getting done. Tribeca Strategic Acquisition Corp. raised $140 million in a SPAC IPO on May 29. Quartzsea Acquisition and Lionheart Holdings have June extension votes coming up, Boardroom Alpha said in its latest SPAC market update. That means Wintergreen is still in a space where new deals, extension votes, and redemption questions are in play.

The setup isn’t locked in. Wintergreen still faces the SEC registration process and needs shareholder approvals. The merged company has to keep at least $5,000,001 in net tangible assets. The S-4 notes Wintergreen’s board didn’t get a fairness opinion from an independent financial adviser. The 10-Q adds that if a business combination doesn’t close by May 30, 2027, mandatory liquidation kicks in and there’s substantial doubt about the company as a going concern.

Looking to this week, focus shifts away from earnings and turns to filings. Traders are watching for updates from KIKA, including amended or effective proxy statements, meeting dates, redemption info, or any new disclosures.

Wall Street’s major indexes ended at new highs Friday, Reuters said, with tech leading gains and investors watching Middle East deal progress. That’s been a tailwind for Wintergreen, though the real test is if the KIKA vote picture sharpens. For now, risk appetite is in play.

Stock Market Today

  • Cochlear Shares Recover Slightly in May After April Crash
    May 31, 2026, 6:29 PM EDT. Cochlear Ltd shares rebounded about 7% in May to $100.50 after plunging 41% in a single session in April due to a severe earnings downgrade. Despite the recovery, shares remain down 61.5% year-to-date and 63% over 12 months. The modest bounce was driven by bargain hunting, positive broker outlooks predicting over 100% upside, and CEO Dig Howitt's assertion that volume weakness is temporary amid growing demand for cochlear implants. Challenges persist, including hospital capacity constraints, referral reductions, a $25 million foreign exchange hit, and uncertainty from Middle East receivables. Brokers have cut price targets substantially. Overall, Cochlear's market share remains strong but near-term earnings visibility is limited, signaling a cautious outlook for investors.